Trial intelligence / Profile preview

Preload versus afterload hydroxyethyl starch in elective cesarean section under spinal anesthesia

ACTRN12616000252415Phase 4Completed

Sponsor
Guanghan Pharmaceutical
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of hetastarch in pregnancy, sponsored by Guanghan Pharmaceutical. Primary endpoints: Cardiac output, Mean arterial pressure and 1 more. Started May 2014; status: completed.

02

Drugs

hetastarch
03

Conditions

pregnancy

Beyond the preview

Go deeper on ACTRN12616000252415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616000252415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call